- Home
- ADMA vs TGS Comparison
ADMA vs TGS Comparison
Compare ADMA & TGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- TGS
- Stock Information
- Founded
- ADMA 2004
- TGS 1992
- Country
- ADMA United States
- TGS Argentina
- Employees
- ADMA N/A
- TGS N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- TGS Natural Gas Distribution
- Sector
- ADMA Health Care
- TGS Utilities
- Exchange
- ADMA Nasdaq
- TGS Nasdaq
- Market Cap
- ADMA 5.1B
- TGS 4.4B
- IPO Year
- ADMA N/A
- TGS N/A
- Fundamental
- Price
- ADMA $15.69
- TGS $22.26
- Analyst Decision
- ADMA Strong Buy
- TGS Strong Buy
- Analyst Count
- ADMA 3
- TGS 1
- Target Price
- ADMA $27.67
- TGS $40.00
- AVG Volume (30 Days)
- ADMA 2.9M
- TGS 647.7K
- Earning Date
- ADMA 11-06-2025
- TGS 11-03-2025
- Dividend Yield
- ADMA N/A
- TGS 4.18%
- EPS Growth
- ADMA 469.09
- TGS 69.56
- EPS
- ADMA 0.85
- TGS 0.35
- Revenue
- ADMA $474,174,000.00
- TGS $1,027,524,722.00
- Revenue This Year
- ADMA $21.08
- TGS N/A
- Revenue Next Year
- ADMA $25.98
- TGS N/A
- P/E Ratio
- ADMA $18.53
- TGS $12.36
- Revenue Growth
- ADMA 43.58
- TGS 2.37
- 52 Week Low
- ADMA $13.50
- TGS $18.15
- 52 Week High
- ADMA $25.67
- TGS $34.37
- Technical
- Relative Strength Index (RSI)
- ADMA 36.86
- TGS 38.24
- Support Level
- ADMA $15.14
- TGS $21.01
- Resistance Level
- ADMA $17.17
- TGS $24.01
- Average True Range (ATR)
- ADMA 0.55
- TGS 1.31
- MACD
- ADMA -0.12
- TGS -0.44
- Stochastic Oscillator
- ADMA 22.59
- TGS 22.94
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.